This factsheet summarises information and statistics on new psychoactive substances gathered from recent reports on prevalence, treatment, mortality and legislation in Ireland.
Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries.
This briefing describes the rationale and methodology of the...
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS).
This is an extensive and comprehensive...
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
This report presents the latest clinical evidence on how cannabis use during pregnancy and breastfeeding can affect a developing fetus and infant.
Key points include: the effects of cannabis can be passed onto the fetus through the...
This comprehensive report details the full extent of the way that alcohol is being marketed across national borders – often by digital means – and often regardless of the social, economic or cultural environment in receiving countries.
It...
The need to change our language in relation to people who use drugs has become an increasing topic of discussion, but there is still a long way to go. People who use drugs are highly diverse and their relationship with drug use takes many...
The quality standard highlights five key areas for improvement:
To investigate how alcohol container labels can be used to build public awareness, the Canadian Centre on Substance Use and Addiction commissioned Enhanced Alcohol Container Labels: A Systematic Review and developed a summary of the report...
The Institute of Global Homelessness (IGH) drives a global movement to end street homelessness. Their vision is a world where everyone has a home that offers security, safety, autonomy, and opportunity.
This paper, published by IGH...
The European Web Survey on Drugs collected data between March and April 2021 from people who use drugs, aged 18 or older, living in 21 EU and 9 non-EU countries. During this period the populations in many European countries were...
This briefing synthesises existing evidence on alcohol energy (calorie) labelling, spanning the past five years (2016-2021).
This briefing covers reviews in the academic literature about the impact of alcohol energy labelling, studies and...
The Canadian Centre on Substance Use and Addiction (CCSA) provided funding to Dr. Akwasi Owusu-Bempah and Dr. Scot Wortley from the University of Toronto to research youth interactions with the criminal justice system, including the nature...
The Canadian Centre for Substance Use and Addiction (CCSA) in partnership with the Royal Ottawa Mental Health Centre, the Canadian Psychological Association and Canada Health Infoway, collected national data on the experience and...
The Canadian Centre on Substance Use and Addiction (CCSA) has released Updating Canadian Low-Risk Alcohol Drinking Guidelines: Summary of Findings from Public Consultation. This report marks an important phase in the process of updating...
This report provides a technical review of the current body of knowledge regarding synthetic cannabinoids that are monitored by the the EU Early Warning System.
The aim of this report is to strengthen situational awareness of synthetic...
The UNODC Regional Program Office for Eastern Europe (Kiev, Ukraine), in collaboration with the Humanitarian Action Fund (St. Petersburg, Russia), issues recommendations on web outreach for people who use drugs (PWUD), including people who...
